antihemophilic factor viii (Recombinant), porcine sequence (Obizur) Report issue

Active Ingredient History

  • Now
Susoctocog alfa, sold under the brand name Obizur, is a medication used for the treatment of bleeding episodes in adults with acquired haemophilia, a bleeding disorder caused by the spontaneous development of antibodies that inactivate factor VIII.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
antihemophilic factor (recombinant), porcine sequence | obi-1 | obizur | porcine coagulation factor viii | recombinant porcine antihemophilic factor | susoctocog alfa


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue